MAPK1 and breast carcinoma: Therefore, in this model of mammary epithelial cell transformation, TDAG51 acts as a growth inhibitor of ERK-driven proliferation and may help explain why loss of TDAG51 expression has been found to correlate with progression in human breast cancer and melanoma.